Endotheliopathy in acute COVID-19 and long COVID
AG Vassiliou, CS Vrettou, C Keskinidou… - International Journal of …, 2023 - mdpi.com
The pulmonary endothelium is a highly regulated organ that performs a wide range of
functions under physiological and pathological conditions. Since endothelial dysfunction …
functions under physiological and pathological conditions. Since endothelial dysfunction …
Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: possible paths to platelet factor 4 autoimmunity
M Goldman, C Hermans - PLoS medicine, 2021 - journals.plos.org
Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible
paths to platelet factor 4 autoimmunity | PLOS Medicine Skip to main content Advertisement …
paths to platelet factor 4 autoimmunity | PLOS Medicine Skip to main content Advertisement …
Does COVID-19 cause hypertension?
M Akpek - Angiology, 2022 - journals.sagepub.com
The coronavirus disease 2019 (COVID-19) outbreak remains a major public health
challenge worldwide. The present study investigated the effect of COVID-19 on blood …
challenge worldwide. The present study investigated the effect of COVID-19 on blood …
Systematic review of endocan as a potential biomarker of COVID-19
A Khalaji, N Amirkhani, S Sharifkashani… - …, 2024 - journals.sagepub.com
Since the start of the coronavirus disease 2019 (COVID-19) pandemic, several biomarkers
have been proposed to assess the diagnosis and prognosis of this disease. The present …
have been proposed to assess the diagnosis and prognosis of this disease. The present …
Endothelial, immunothrombotic, and inflammatory biomarkers in the risk of mortality in critically ill COVID-19 patients: the role of dexamethasone
C Keskinidou, AG Vassiliou, A Zacharis, E Jahaj… - Diagnostics, 2021 - mdpi.com
Endothelial dysfunction, coagulation and inflammation biomarkers are increasingly
emerging as prognostic markers of poor outcomes and mortality in severe and critical …
emerging as prognostic markers of poor outcomes and mortality in severe and critical …
Changes in plasma endocan level are related to circulatory but not respiratory failure in critically ill patients with COVID-19
M Lipińska-Gediga, A Lemańska-Perek, W Gozdzik… - Scientific Reports, 2023 - nature.com
The aim of this prospective, observational study was to assess whether changes in the level
of endocan, a marker of endothelial damage, may be an indicator of clinical deterioration …
of endocan, a marker of endothelial damage, may be an indicator of clinical deterioration …
Novel inflammatory biomarkers in the prognosis of COVID-19
K Zhan, L Wang, H Lin, X Fang… - … in Respiratory Disease, 2023 - journals.sagepub.com
Background: The central role of inflammatory progression in the development of
Coronavirus disease 2019 (COVID-19), especially in severe cases, is indisputable …
Coronavirus disease 2019 (COVID-19), especially in severe cases, is indisputable …
COVID-19 and inflammatory markers
S Balta, I Balta - Current Vascular Pharmacology, 2022 - ingentaconnect.com
Coronavirus disease-2019 (COVID-19) causes mild illness to serious infection with lung
involvement, thrombosis, and other complications potentially resulting in fatal outcomes …
involvement, thrombosis, and other complications potentially resulting in fatal outcomes …
[PDF][PDF] Severe vitamin D deficiency is associated with endothelial inflammation in healthy individuals even in the absence of subclinical atherosclerosis.
OBJECTIVE: Vitamin D has beneficial effects, some of which involve the cardiovascular
system. No study to date has investigated the association between serum endocan levels …
system. No study to date has investigated the association between serum endocan levels …
Diagnostic and prognostic value of serum endocan levels in patients with COVID-19
We aimed to evaluate whether there was a relationship between endocan (human
endothelial cell-specific molecule-1) levels and disease prognosis in patients who …
endothelial cell-specific molecule-1) levels and disease prognosis in patients who …